Yaws

MMarks; OMitja; AWSolomon; KBAsiedu; DCMabey; (2015) Yaws. British Medical Bulletin, 113 (1). pp. 91-100. ISSN 0007-1420 DOI: 10.1093/bmb/ldu037
Copy

Introduction Yaws, caused by Treponema pallidum ssp. pertenue, is endemic in parts of West Africa, Southeast Asia and the Pacific. The WHO has launched a campaign based on mass treatment with azithromycin, to eradicate yaws by 2020.

Sources of data We reviewed published data, surveillance data and data presented at yaws eradication meetings.

Areas of agreement Azithromycin is now the preferred agent for treating yaws. Point-of-care tests have demonstrated their value in yaws.

Areas of controversy There is limited data from 76 countries, which previously reported yaws. Different doses of azithromycin are used in community mass treatment for yaws and trachoma.

Growing points Yaws eradication appears an achievable goal. The programme will require considerable support from partners across health and development sectors.

Areas timely for developing research Studies to complete baseline mapping, integrate diagnostic tests into surveillance and assess the impact of community mass treatment with azithromycin are ongoing.



picture_as_pdf
Br Med Bull-2015-Marks-91-100.pdf
subject
Published Version
Available under Creative Commons: 3.0

View Download

Explore Further

Read more research from the creator(s):

Find work funded by this grant:

Find work associated with the faculties and division(s):

Find work from this publication: